from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2423/-

LFCtreatmentdescriptionclass of inhibitor

0.034

Amikacinug/mL Amikacintranslation

0.226

Cap5-10ug/mL Capreomycintranslation

-0.983

Rox10-50 ug/mL Roxithromycintranslation

-0.900

SM2-5 ug/mL Streptomycintranslation

0.371

Tet5-10 ug/mL Tetracyclinetranslation

2.193

Rif0.2-5ug/mL Rifampicintranscription

1.081

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.081

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.279

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.182

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.216

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.073

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.811

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.164

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.391

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.397

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.247

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.052

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.096

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.434

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.525

KCN5-20 ug/mL Potassium cyaniderespiration

-0.737

NaN30.2-2 mM Sodium aziderespiration

-0.616

Nigericin50 uM Nigericinrespiration

0.827

TRC10-150 ug/mL Triclosanrespiration

0.966

TRZ10-25 ug/mL Thioridazinerespiration

-0.114

Valinomycin0.5-10 uM Valinomycinrespiration

-0.435

ZnSO42 mM ZnSO4respiration

-0.064

menadione6-10 ug/mL Menadionerespiration

0.146

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.794

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.520

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.699

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.650

NRP_1Non-replicating persistence stage 1dosRassociated

-0.368

Amp0.2mg/mL AmpicillincellWall

-0.086

Cephalexin20-100 ug/mL CephalexincellWall

-0.568

Cerulenin0.32-5 ug/mL CerulenincellWall

1.143

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.648

EMB10-20 ug/mL EthambutolcellWall

-0.563

Eta12-40 ug/mL EthionamidecellWall

-0.864

INH0.2-0.4 ug/mL IsoniazidcellWall

0.289

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.368

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.185

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.207

BZA0.12 mg/mL BenzamidearomaticAmides

-0.345

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.769

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.851

H2O24 mM hydrogen peroxideDNAdamaging

-0.019

Levo10 ug/mL LevofloxacinDNAdamaging

-0.039

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.790

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.448

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.091

UVUV-irradiationDNAdamaging

1.254

ARP41-4 ug/mL Antitubercular compound ARP4?

0.346

Antimycin12.5-50 ug/mL Antimycin A?

-0.056

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.744

PA_110-50 ug/mL Antitubercular compound PA-1?

0.825

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.896

PA8240.2-2 ug/mL PA-824?

-0.144

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.080

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.358

Verapamil50 uM Verapamil?

0.091

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.128

methoxatin10-20 ug/mL Methoxatin?